Search
for
Sort by
Research 121–150 of 1000+
- The Rotterdam Study: 2018 update on objectives, design and main results
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Insights into the angiogenic effects of nanomaterials: mechanisms involved and potential applications
- HRT for women with premature ovarian insufficiency: a comprehensive review
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Interval training and cardiometabolic health in reproductive-aged females
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Farmácia do Lago, Porto e nos Serviços Farmacêuticos do Nemocnica Akademika Ladislava Dérera (Kramáre Hospital), Eslováquia
- Drug news and therapeutic news
- Reporting on Adverse Clinical Events
- Medicinal Uses of L-Lysine: Past and Future
- Hot topics in research and patient care in Dermatology and Venereology, 2019
- Anti-anginal and beta-adrenoceptor blocking drugs
- The role of androgens in hormone replacement therapy
- Ottawa, Ontario, Canada, February 13–16, 2013
- Androgen Treatment in Women
- Cardiovascular effects of hormone therapy for prostate cancer
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study